Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

C Heneghan; C Blacklock; R Perera; R Davis; A Banerjee; P Gill; S Liew; L Chamas; J Hernandez; K Mahtani; G Hayward; S Harrison; D Lasserson; S Mickan; C Sellers; D Carnes; K Homer; L Steed; J Ross; N Denny; C Goyder; M Thompson; A Ward

doi:10.1136/bmjopen-2013-003298

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

C Heneghan, C Blacklock, R Perera, R Davis, A Banerjee, P Gill, S Liew, L Chamas, J Hernandez, K Mahtani, G Hayward, S Harrison, D Lasserson, S Mickan, C Sellers, D Carnes, K Homer, L Steed, J Ross, N DennyC Goyder, M Thompson, A Ward

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Abstract

Prevalence of non-communicable diseases (NCDs) is increasing globally, with the greatest projected increases in low-income and middle-income countries. We sought to quantify the proportion of Cochrane evidence relating to NCDs derived from such countries.

Original language	English
Journal	BMJ open
Volume	3
Issue number	7
DOIs	https://doi.org/10.1136/bmjopen-2013-003298
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmjopen-2013-003298

Cite this

Heneghan, C., Blacklock, C., Perera, R., Davis, R., Banerjee, A., Gill, P., Liew, S., Chamas, L., Hernandez, J., Mahtani, K., Hayward, G., Harrison, S., Lasserson, D., Mickan, S., Sellers, C., Carnes, D., Homer, K., Steed, L., Ross, J., ... Ward, A. (2013). Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ open, 3(7). https://doi.org/10.1136/bmjopen-2013-003298

@article{6368b5e61d5c4bb6aeaa332dfb92b1e3,

title = "Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification",

abstract = "Prevalence of non-communicable diseases (NCDs) is increasing globally, with the greatest projected increases in low-income and middle-income countries. We sought to quantify the proportion of Cochrane evidence relating to NCDs derived from such countries.",

author = "C Heneghan and C Blacklock and R Perera and R Davis and A Banerjee and P Gill and S Liew and L Chamas and J Hernandez and K Mahtani and G Hayward and S Harrison and D Lasserson and S Mickan and C Sellers and D Carnes and K Homer and L Steed and J Ross and N Denny and C Goyder and M Thompson and A Ward",

year = "2013",

doi = "10.1136/bmjopen-2013-003298",

language = "English",

volume = "3",

journal = "BMJ open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "7",

}

Heneghan, C, Blacklock, C, Perera, R, Davis, R, Banerjee, A, Gill, P, Liew, S, Chamas, L, Hernandez, J, Mahtani, K, Hayward, G, Harrison, S, Lasserson, D, Mickan, S, Sellers, C, Carnes, D, Homer, K, Steed, L, Ross, J, Denny, N, Goyder, C, Thompson, M & Ward, A 2013, 'Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification', BMJ open, vol. 3, no. 7. https://doi.org/10.1136/bmjopen-2013-003298

TY - JOUR

T1 - Evidence for non-communicable diseases

T2 - analysis of Cochrane reviews and randomised trials by World Bank classification

AU - Heneghan, C

AU - Blacklock, C

AU - Perera, R

AU - Davis, R

AU - Banerjee, A

AU - Gill, P

AU - Liew, S

AU - Chamas, L

AU - Hernandez, J

AU - Mahtani, K

AU - Hayward, G

AU - Harrison, S

AU - Lasserson, D

AU - Mickan, S

AU - Sellers, C

AU - Carnes, D

AU - Homer, K

AU - Steed, L

AU - Ross, J

AU - Denny, N

AU - Goyder, C

AU - Thompson, M

AU - Ward, A

PY - 2013

Y1 - 2013

N2 - Prevalence of non-communicable diseases (NCDs) is increasing globally, with the greatest projected increases in low-income and middle-income countries. We sought to quantify the proportion of Cochrane evidence relating to NCDs derived from such countries.

AB - Prevalence of non-communicable diseases (NCDs) is increasing globally, with the greatest projected increases in low-income and middle-income countries. We sought to quantify the proportion of Cochrane evidence relating to NCDs derived from such countries.

U2 - 10.1136/bmjopen-2013-003298

DO - 10.1136/bmjopen-2013-003298

M3 - Article

C2 - 23833146

SN - 2044-6055

VL - 3

JO - BMJ open

JF - BMJ open

IS - 7

ER -

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this